United States· US:82448-150_9180a538-c66a-430d-b32b-aab276e12201
OGSIVEO
A nirogacestat product containing nirogacestat, registered in United States by SpringWorks Therapeutics, Inc.. The same ATC class is registered in 9 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Nirogacestat is registered in 9 of 19 countries.
Countries holding a registration under ATC L01XX81 (nirogacestat), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Nirogacestat · ATC L01XX81
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Spainprice
- Switzerlandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NIROGACESTAT
- Manufacturer
- SpringWorks Therapeutics, Inc.
- Country
- United States (US)
- ATC code
- L01XX81
- ATC class
- Nirogacestat
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- August 30, 2026
Packs & prices · 1
- ndc1182448-150-14
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nirogacestat in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandOgsiveo 150 mg, FilmtablettenMerck (Schweiz) AG
- CzechiaOGSIVEOMerck Europe B.V., Amsterdam
- SpainOGSIVEO 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULAMerck Europe B.V.
- FinlandOgsiveoMerck Europe B.V.
- BelgiumOgsiveo 150 mgMerck Europe
- IrelandOgsiveo 150 mg film‑coated tabletsMerck Europe B.V.
- IcelandOgsiveoMerck Europe B.V.*
- PolandOgsiveoSpringWorks Therapeutics Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ogsiveo
- Liechtenstein · Ogsiveo
- Norway · Ogsiveo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/46a64e74-bb71-42c1-8876-9c9d0160ed22 GET /v1/drugs/46a64e74-bb71-42c1-8876-9c9d0160ed22?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "150",
"substance": "NIROGACESTAT",
"productndc": "82448-150",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA217677",
"marketing_category": "NDA"
}See everything about nirogacestat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.